Stocks and Investing Stocks and Investing
Mon, August 21, 2023
Fri, August 18, 2023

Luca Issi Reiterated (ALNY) at Buy and Held Target at $270 on, Aug 18th, 2023


Published on 2024-10-28 06:01:19 - WOPRAI, Luca Issi
  Print publication without navigation


Luca Issi of RBC Capital, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy and Held Target at $270 on, Aug 18th, 2023.

Luca has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 3 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $190 on, Wednesday, August 16th, 2023
  • Michael Ulz of "Morgan Stanley" Reiterated at Hold and Held Target at $210 on, Friday, August 4th, 2023
  • David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023


These are the ratings of the 5 analyists that currently disagree with Luca


  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $405 on, Monday, August 7th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $266 on, Friday, August 4th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, August 4th, 2023
  • Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023
Contributing Sources